Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder
Conditions: Agitation Associated With Schizophrenia or Bipolar Disorder; Bipolar Disorder; Schizophrenia; Agitation,Psychomotor Intervention: Drug: Sublingual film containing Igalmi Sponsors: BioXcel Therapeutics Inc; Lotus Clinical Research, LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder
Conditions: Bipolar Disorder; Schizophrenia; Agitation,Psychomotor; Schizo Affective Disorder; Schizophreniform Disorders Intervention: Drug: Sublingual film containing Igalmi Sponsors: BioXcel Therapeutics Inc; Lotus Clinical Research, LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder
Conditions: Agitation Associated With Schizophrenia or Bipolar Disorder; Bipolar Disorder; Schizophrenia; Agitation,Psychomotor Intervention: Drug: Sublingual film containing Igalmi Sponsors: BioXcel Therapeutics Inc; Lotus Clinical Research, LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
NRX Pharmaceuticals Announces Data Sharing Agreement Demonstrating Efficacy and Safety of Intravenous Ketamine for the Treatment of Suicidal Bipolar Depression
RADNOR, Pa., Sept. 15, 2023. NRx Pharmaceuticals, Inc. ( " NRx Pharmaceuticals " , the " Company " ), a clinical-stage biopharmaceutical company, today announced that it has signed a data sharing agreement with the study leadership of a randomized,... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 16, 2023 Category: Pharmaceuticals Source Type: clinical trials
Oral and Jaw Health in Bipolar Patients
Conditions: Bipolar Disorders; Oral Health Intervention: Sponsor: Bandırma Onyedi Eylül University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Validation of the French Version of the Lithium Knowledge Test (LKT)
Condition: Patient Treated With Lithium, With Bipolar or Schizo-affective Disorder, Hospitalized in a Psychiatric Ward Intervention: Sponsor: University Hospital, Lille Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Oral and Jaw Health in Bipolar Patients
Conditions: Bipolar Disorders; Oral Health Intervention: Sponsor: Bandırma Onyedi Eylül University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Validation of the French Version of the Lithium Knowledge Test (LKT)
Condition: Patient Treated With Lithium, With Bipolar or Schizo-affective Disorder, Hospitalized in a Psychiatric Ward Intervention: Sponsor: University Hospital, Lille Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
